Roche's experimental multiple sclerosis drug achieved its main goal in one of two key late-stage trials testing it against ...

HCW11-040 is a first-in-class pembrolizumab-based, tetra-valent immune checkpoint inhibitor designated as Company’s franchise ...

The solution to the housing affordability crisis is not to make mortgages cheaper, but to lower housing prices with increased supply.

It's difficult to put an exact price tag on how much index funds have saved investors since their creation in 1975. But it's ...

The Watchdog welcomes the news that a new state law creates a requirement for all Texas public school students to take a mandatory “financial literacy” class in high school. Maybe this happened to you ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.

Meg Alexander appointed Chief Executive Officer effective January 1, 2026; Dr. Jeremy M. Levin to transition to Executive ...

SJR10 urges Congress to support federal reforms that will finally open the door to psychedelic-assisted therapies.

HCW Biologics debuted the results from its preclinical study of HCW11-018b, the Company’s lead T-cell engager product candidate, that highlights the uniqueness and advantages of its second-generation ...

Strategic process -- Formal engagement with Evercore concluded; current focus is on Phase III clinical execution, with ...

Q3 2025 Earnings Call Transcript November 10, 2025 Pagaya Technologies Ltd. misses on earnings expectations. Reported EPS is ...

Researchers linked a new PFAS chemical, PFHpA, to worsening liver disease in teens with obesity, raising fresh concerns about hidden toxins.